Xilio Therapeutics, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Xilio Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
  • Xilio Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $400K, a 20% decline year-over-year.
  • Xilio Therapeutics, Inc. annual Depreciation for 2023 was $1.8M, a 5.88% increase from 2022.
  • Xilio Therapeutics, Inc. annual Depreciation for 2022 was $1.7M, a 21.4% increase from 2021.
  • Xilio Therapeutics, Inc. annual Depreciation for 2021 was $1.4M, a 27.3% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.8M +$100K +5.88% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $1.7M +$300K +21.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $1.4M +$300K +27.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $1.1M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.